Skip to main content
Erschienen in: Cardiovascular Toxicology 3/2017

19.12.2016

Doxorubicin and Liposomal Doxorubicin Differentially Affect Expression of miR-208a and let-7g in Rat Ventricles and Atria

verfasst von: Jan Novak, Jiri Sana, Tibor Stracina, Marie Novakova, Ondrej Slaby

Erschienen in: Cardiovascular Toxicology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Anthracyclines use is limited by profound cardiotoxicity. Involvement of miRNAs in anthracycline-induced cardiotoxicity (AIC) is still not completely understood. Thus, the expression of AIC-related microRNAs was determined in rat atria and ventricles after doxorubicin (DOX) and liposomal doxorubicin (L-DOX) administration. Vehiculum, DOX or L-DOX were applied intraperitoneally in a single dose to male Wistar rats (3 groups: control, DOX and L-DOX, respectively). Rats were sacrificed after 24 h, and samples from left atrium (LA)/ventricle (LV) and right atrium (RA)/ventricle (RV) were obtained. Expressions of miR-208a, let-7g and snU6 were determined using qRT-PCR. In the control group, miR-208a was highly abundant in the atria compared to the ventricles and in the left-sided structures compared to the right-sided structures, while let-7g showed only atrio-ventricular gradient with predominant expression in the atria. Administration of both DOX and L-DOX resulted in 38.87 and 23.57% reduction in miR-208a expression in the LV (p = 0.028) and in 13.79 and 14.70% reduction in let-7g expression in the LA (p = 0.015), respectively. Acute administration of DOX/L-DOX alters expression of miR-208a in LV and of let-7g in LA. These changes may partly contribute to the development of AIC.
Literatur
1.
Zurück zum Zitat Gianni, L., Herman, E. H., Lipshultz, S. E., Minotti, G., Sarvazyan, N., & Sawyer, D. B. (2008). Anthracycline cardiotoxicity: From bench to bedside. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 26(22), 3777–3784. doi:10.1200/JCO.2007.14.9401.CrossRef Gianni, L., Herman, E. H., Lipshultz, S. E., Minotti, G., Sarvazyan, N., & Sawyer, D. B. (2008). Anthracycline cardiotoxicity: From bench to bedside. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 26(22), 3777–3784. doi:10.​1200/​JCO.​2007.​14.​9401.CrossRef
2.
Zurück zum Zitat Octavia, Y., Tocchetti, C. G., Gabrielson, K. L., Janssens, S., Crijns, H. J., & Moens, A. L. (2012). Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies. Journal of Molecular and Cellular Cardiology, 52(6), 1213–1225. doi:10.1016/j.yjmcc.2012.03.006.CrossRefPubMed Octavia, Y., Tocchetti, C. G., Gabrielson, K. L., Janssens, S., Crijns, H. J., & Moens, A. L. (2012). Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies. Journal of Molecular and Cellular Cardiology, 52(6), 1213–1225. doi:10.​1016/​j.​yjmcc.​2012.​03.​006.CrossRefPubMed
3.
Zurück zum Zitat Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 75(5), 843–854.CrossRefPubMed Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 75(5), 843–854.CrossRefPubMed
7.
Zurück zum Zitat Drbohlavova, J., Chomoucka, J., Adam, V., Ryvolova, M., Eckschlager, T., Hubalek, J., et al. (2013). Nanocarriers for anticancer drugs–new trends in nanomedicine. Current Drug Metabolism, 14(5), 547–564.CrossRefPubMed Drbohlavova, J., Chomoucka, J., Adam, V., Ryvolova, M., Eckschlager, T., Hubalek, J., et al. (2013). Nanocarriers for anticancer drugs–new trends in nanomedicine. Current Drug Metabolism, 14(5), 547–564.CrossRefPubMed
9.
Zurück zum Zitat van Rooij, E., Sutherland, L. B., Qi, X., Richardson, J. A., Hill, J., & Olson, E. N. (2007). Control of stress-dependent cardiac growth and gene expression by a microRNA. Science (New York, N.Y.), 316(5824), 575–579. doi:10.1126/science.1139089.CrossRef van Rooij, E., Sutherland, L. B., Qi, X., Richardson, J. A., Hill, J., & Olson, E. N. (2007). Control of stress-dependent cardiac growth and gene expression by a microRNA. Science (New York, N.Y.), 316(5824), 575–579. doi:10.​1126/​science.​1139089.CrossRef
11.
Zurück zum Zitat Pasquinelli, A. E., Reinhart, B. J., Slack, F., Martindale, M. Q., Kuroda, M. I., Maller, B., et al. (2000). Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature, 408(6808), 86–89. doi:10.1038/35040556.CrossRefPubMed Pasquinelli, A. E., Reinhart, B. J., Slack, F., Martindale, M. Q., Kuroda, M. I., Maller, B., et al. (2000). Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature, 408(6808), 86–89. doi:10.​1038/​35040556.CrossRefPubMed
13.
14.
Zurück zum Zitat Luo, X., Zhang, H., Xiao, J., & Wang, Z. (2010). Regulation of human cardiac ion channel genes by microRNAs: theoretical perspective and pathophysiological implications. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 25(6), 571–586. doi:10.1159/000315076.CrossRef Luo, X., Zhang, H., Xiao, J., & Wang, Z. (2010). Regulation of human cardiac ion channel genes by microRNAs: theoretical perspective and pathophysiological implications. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 25(6), 571–586. doi:10.​1159/​000315076.CrossRef
Metadaten
Titel
Doxorubicin and Liposomal Doxorubicin Differentially Affect Expression of miR-208a and let-7g in Rat Ventricles and Atria
verfasst von
Jan Novak
Jiri Sana
Tibor Stracina
Marie Novakova
Ondrej Slaby
Publikationsdatum
19.12.2016
Verlag
Springer US
Erschienen in
Cardiovascular Toxicology / Ausgabe 3/2017
Print ISSN: 1530-7905
Elektronische ISSN: 1559-0259
DOI
https://doi.org/10.1007/s12012-016-9393-8

Weitere Artikel der Ausgabe 3/2017

Cardiovascular Toxicology 3/2017 Zur Ausgabe